XMOV.DE vs. 2B70.DE
XMOV.DE (Xtrackers Future Mobility UCITS ETF) and 2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) are both exchange-traded funds - XMOV.DE is a Technology Equities fund tracking the Nasdaq Global Future Mobility, while 2B70.DE is a Health & Biotech Equities fund tracking the Nasdaq Biotechnology. Both are passively managed. Over the past 5 years, XMOV.DE returned 13.95%/yr vs 6.01%/yr for 2B70.DE. At a 0.44 correlation, their price movements are largely independent. Both charge a 0.35% expense ratio.
Performance
XMOV.DE vs. 2B70.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XMOV.DE achieves a 25.87% return, which is significantly higher than 2B70.DE's 14.41% return.
XMOV.DE
- 1D
- -0.03%
- 1M
- -1.73%
- YTD
- 25.87%
- 6M
- 26.51%
- 1Y
- 49.37%
- 3Y*
- 23.71%
- 5Y*
- 13.95%
- 10Y*
- —
2B70.DE
- 1D
- 0.86%
- 1M
- 10.24%
- YTD
- 14.41%
- 6M
- 14.41%
- 1Y
- 54.92%
- 3Y*
- 14.71%
- 5Y*
- 6.01%
- 10Y*
- —
XMOV.DE vs. 2B70.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
XMOV.DE Xtrackers Future Mobility UCITS ETF | 25.87% | 14.79% | 20.92% | 46.97% | -25.82% | 22.52% | 13.89% | -0.98% |
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 14.41% | 18.57% | 4.69% | 2.49% | -6.33% | 7.72% | 14.37% | 16.23% |
Correlation
The correlation between XMOV.DE and 2B70.DE is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.40 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Jan 29, 2019 | 0.44 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XMOV.DE vs. 2B70.DE — Risk / Return Rank
XMOV.DE
2B70.DE
XMOV.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers Future Mobility UCITS ETF (XMOV.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XMOV.DE | 2B70.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.47 | ||
| Sortino ratioReturn per unit of downside risk | -0.70 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.45 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 4.52 | 8.71 | -4.19 |
| Martin ratioReturn relative to average drawdown | 15.42 | 25.37 | -9.95 |
Loading charts...
Drawdowns
XMOV.DE vs. 2B70.DE - Drawdown Comparison
The maximum XMOV.DE drawdown since its inception was -35.78%, which is greater than 2B70.DE's maximum drawdown of -30.92%. Use the drawdown chart below to compare losses from any high point for XMOV.DE and 2B70.DE.
Loading charts...
Drawdown Indicators
| XMOV.DE | 2B70.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.78% | -30.92% | -4.86% |
Max Drawdown (1Y)Largest decline over 1 year | -10.87% | -6.28% | -4.59% |
Max Drawdown (3Y)Largest decline over 3 years | -24.70% | -29.42% | +4.72% |
Max Drawdown (5Y)Largest decline over 5 years | -30.32% | -30.92% | +0.60% |
Current DrawdownCurrent decline from peak | -3.28% | 0.00% | -3.28% |
Average DrawdownAverage peak-to-trough decline | -8.39% | -11.75% | +3.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.19% | 2.16% | +1.03% |
Volatility
XMOV.DE vs. 2B70.DE - Volatility Comparison
Xtrackers Future Mobility UCITS ETF (XMOV.DE) has a higher volatility of 8.83% compared to iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) at 6.66%. This indicates that XMOV.DE's price experiences larger fluctuations and is considered to be riskier than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XMOV.DE | 2B70.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.83% | 6.66% | +2.17% |
Volatility (6M)Calculated over the trailing 6-month period | 17.70% | 15.00% | +2.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.29% | 19.69% | +1.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.64% | 20.49% | -0.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.33% | 22.35% | -1.02% |
XMOV.DE vs. 2B70.DE - Expense Ratio Comparison
Both XMOV.DE and 2B70.DE have an expense ratio of 0.35%.
Dividends
XMOV.DE vs. 2B70.DE - Dividend Comparison
Neither XMOV.DE nor 2B70.DE has paid dividends to shareholders.
Frequently Asked Questions
XMOV.DE and 2B70.DE have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
XMOV.DE and 2B70.DE have the same expense ratio: 0.35% per year.
XMOV.DE is categorized as Technology Equities, while 2B70.DE is Health & Biotech Equities. XMOV.DE tracks Nasdaq Global Future Mobility, while 2B70.DE tracks Nasdaq Biotechnology. They also come from different issuers: Xtrackers and iShares.
Find the right allocation for XMOV.DE and 2B70.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer